We are live on ! Find out more

OXFD

Oxford Immunotec Global PLC Ordinary Shares

OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

57 hedge funds and large institutions have $179M invested in Oxford Immunotec Global PLC Ordinary Shares in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 11 closing their positions.

New

Increased

Maintained

Reduced

Closed

62% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

12% less funds holding

Funds holding: 65 → 57 (-8)

14% less capital invested

Capital invested by funds: $209M → $179M (-$30.2M)

73% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 11

Holders

Holders Change

-8

Holders Change %

-12.31%

% of All Funds

1.52%

Holding in Top 10

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

0.05%

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

Rank	Fund	Capital Flow
1	ACP Acuta Capital Partners Redwood City, California	+$1.21M
2	FLAM First Light Asset Management Edina, Minnesota	+$472K
3	PC Polar Capital London, United Kingdom	+$323K
4	Renaissance Technologies New York	+$285K
5	GPGA Grandeur Peak Global Advisors Salt Lake City, Utah	+$222K

Top Sellers

Rank	Fund	Capital Flow
1	TAM Tiverton Asset Management Wilimington, Delaware	-$1.14M
2	GIP Granite Investment Partners El Segundo, California	-$984K
3	DM Deerfield Management New York	-$565K
4	CC Casdin Capital New York	-$564K
5	Morgan Stanley New York	-$321K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	26 Renaissance Technologies New York	$810K	+$285K	+27,800	+52%
27	BIM 27 BlackRock Investment Management Wilmington, Delaware	$734K	+$19.4K	+1,894	+3%
28	CWG 28 C WorldWide Group Copenhagen, Denmark	$698K	–	–	–
29	TCIM 29 TIAA CREF Investment Management New York	$639K	–	–	–
30	UOC 30 UBS O'Connor Chicago, Illinois	$558K	–	–	–
31	BC 31 Birchview Capital Burlington, Vermont	$558K	+$164K	+16,000	+40%
32	32 Vanguard Group Malvern, Pennsylvania	$540K	-$18.6K	-1,816	-3%
33	SIM 33 Spark Investment Management New York	$522K	-$105K	-10,200	-16%
34	34 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$423K	+$54.9K	+5,357	+14%
35	35 Bank of New York Mellon New York	$407K	+$12.8K	+1,250	+3%
36	36 D.E. Shaw & Co New York	$336K	+$14.6K	+1,423	+4%
37	37 Charles Schwab San Francisco, California	$292K	–	–	–
38	TA 38 Teachers Advisors New York	$291K	–	–	–
39	39 KeyBank National Association Cleveland, Ohio	$230K	–	–	–
40	WSA 40 Wall Street Associates Lajolla, California	$226K	–	–	–
41	CC 41 Casdin Capital New York	$198K	-$564K	-55,000	-73%
42	42 New York State Common Retirement Fund Albany, New York	$182K	–	–	–
43	43 RhumbLine Advisers Boston, Massachusetts	$182K	+$1.13K	+110	+0.6%
44	44 Wells Fargo San Francisco, California	$150K	+$5.33K	+520	+4%
45	45 Citigroup New York	$139K	+$116K	+11,353	+418%
46	46 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	$134K	–	–	–
47	NFA 47 Nationwide Fund Advisors Columbus, Ohio	$134K	–	–	–
48	48 Goldman Sachs New York	$131K	+$136K	+13,244	New
49	BA 49 BlackRock Advisors Wilmington, Delaware	$129K	+$73.5K	+7,164	+122%
50	AIG 50 American International Group New York	$117K	–	–	–

OXFD Hedge Fund Activity: Q1 2016 in Review

57 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q1 2016, worth a combined $179M — down 14% from $209M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of OXFD and 3 opened new positions — a net loss of 8 holders — while 13 trimmed existing stakes and 21 added.

The largest buyer was Acuta Capital Partners, adding an estimated $1.21M. The largest seller was Tiverton Asset Management, cutting an estimated $1.14M.

57 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q1 2016, down from 65 in Q4 2015.
Funds reported $179M of Oxford Immunotec Global PLC Ordinary Shares stock for Q1 2016, down 14% quarter-over-quarter.
3 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q1 2016 and 11 closed out, a net change of -8 holders.
The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q1 2016 was Acuta Capital Partners, an estimated $1.21M added.
The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q1 2016 was Tiverton Asset Management, an estimated $1.14M sold.

Based on aggregated 13F filings for Q1 2016.

Oxford Immunotec Global PLC Ordinary Shares OXFD